Showing 1 - 8 results of 8 for search 'Caroline Ngetsa', query time: 0.04s Refine Results
  1. 1
    Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya

    Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya by Dorcas Okanda, Leonard Ndwiga, Victor Osoti, Nicole Achieng, Juliana Wambua, Caroline Ngetsa, Peter Lubell-Doughtie, Anuraj Shankar, Philip Bejon, Philip Bejon, Lynette Isabella Ochola-Oyier

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR

    Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR by Caroline Ngetsa, Victor Osoti, Dorcas Okanda, Faith Marura, Krupali Shah, Henry Karanja, Daisy Mugo, John Gitonga, Martin Mutunga, Clement Lewa, Benedict Orindi, Philip Bejon, Lynette Isabella Ochola-Oyier

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.

    Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR. by Caroline Ngetsa, Victor Osoti, Dorcas Okanda, Faith Marura, Krupali Shah, Henry Karanja, Daisy Mugo, John Gitonga, Martin Mutunga, Clement Lewa, Benedict Orindi, Philip Bejon, Lynette Isabella Ochola-Oyier

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

    Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya by Louise O. Downs, Cori Campbell, Michael Abouyannis, Mark Otiende, Melissa Kapulu, Christina W. Obiero, Mainga Hamaluba, Caroline Ngetsa, Monique I. Andersson, George Githinji, George Warimwe, Kathy Baisley, J. Anthony G. Scott, Philippa C. Matthews, Anthony Etyang

    Published 2023-12-01
    Get full text
    Article
  5. 5
    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 4; peer review: 2 approved, 2 approved with reservations]

    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 4; peer review: 2 approved, 2... by Mainga Hamaluba, Juliana Wambua, Arjen M. Dondorp, Jennifer Musyoki, Caroline Ngetsa, Oksana Kharabora, Leonard Ndwiga, Zaydah de Laurent, Kevin Wamae, Kelvin Kimenyi, Gabriel Mwambingu, Peter Kalume, Philip Bejon, Jeffrey Bailey, Rob van der Pluijm, Lynette Ochola-Oyier, Jonathan Juliano, Victor Osoti

    Published 2024-03-01
    Get full text
    Article
  6. 6
    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 2; peer review: 2 approved, 1 approved with reservations]

    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 2; peer review: 2 approved, 1... by Mainga Hamaluba, Juliana Wambua, Arjen M. Dondorp, Jennifer Musyoki, Caroline Ngetsa, Oksana Kharabora, Leonard Ndwiga, Zaydah de Laurent, Kevin Wamae, Kelvin Kimenyi, Gabriel Mwambingu, Peter Kalume, Philip Bejon, Jeffrey Bailey, Rob van der Pluijm, Lynette Ochola-Oyier, Jonathan Juliano, Victor Osoti

    Published 2022-12-01
    Get full text
    Article
  7. 7
    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 3; peer review: 2 approved, 2 approved with reservations]

    Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 3; peer review: 2 approved, 2... by Mainga Hamaluba, Juliana Wambua, Arjen M. Dondorp, Jennifer Musyoki, Caroline Ngetsa, Oksana Kharabora, Leonard Ndwiga, Zaydah de Laurent, Kevin Wamae, Kelvin Kimenyi, Gabriel Mwambingu, Peter Kalume, Philip Bejon, Jeffrey Bailey, Rob van der Pluijm, Lynette Ochola-Oyier, Jonathan Juliano, Victor Osoti

    Published 2023-10-01
    Get full text
    Article
  8. 8
    Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial [version 2; peer review: 2 approved]

    Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial [version 2; peer review: 2 approved] by Mainga Hamaluba, Cynthia Mauncho, Neema Mturi, Henry Karanja, Daisy Mugo, James Nyagwange, Caroline Ngetsa, Bernadette Kutima, Samuel Sang, John N. Gitonga, Benjamin Tsofa, Philip Bejon, Naomi Kamau, George Warimwe, Benedict Orindi, Irene Njau, Mwaganyuma Mwatasa, Lynette Ochola-Oyier, Donwilliams Omuoyo, Elizaphan Oloo, Stanley Cheruiyot, Eunice W. Nduati, Roselyne Namayi, Anthony Etyang, Nadia Aliyan, Adrian Hill, Amy Boyd, Marianne Munene, Alexander Douglas, Amek Nyaguara, Sarah Gilbert, Daniel Wright, Teresa Lambe, Charles Agoti, Kadondi Kasera, Alun Davies, Andrew Pollard, Noni Mumba

    Published 2023-11-01
    Get full text
    Article

Search Tools: